Board of Orchid Pharma approves draft scheme of amalgamation and arrangement
At meeting held on 16 December 2021
The Board of Orchid Pharma at its meeting held on 16 December 2021 has approved a draft Scheme of Amalgamation and Arrangement between Dhanuka Laboratories (DLL), the Company and their respective shareholders and creditors, as may be modified from time to time (Scheme) under Sections 230 to 232 of the Companies Act, 2013.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content